SCHEMBL4031619

SCHEMBL4031619

COCC#CCc1cc(Cl)c(Nc2ncnc3cc(OCCCN(CCOC)CCOC)c(OC)cc23)c2c1OCO2

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.53
SRC P12931 8/20 0.52
KDR P35968 12/20 0.51
CSK P41240 3/20 0.51
TEK Q02763 3/20 0.51
EPHB4 P54760 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024202 0.91 SRC (0.56) EGFRSRCKDRCSKTEK
SCHEMBL4020660 0.86 EGFR (0.53) EGFRSRCKDRCSKTEK
SCHEMBL4026562 0.82 EGFR (0.53) EGFRSRCKDRCSKTEK
SCHEMBL4030245 0.80 SRC (0.54) EGFRSRCKDRCSKTEK
SCHEMBL4027299 0.80 SRC (0.56) EGFRSRCKDRCSKTEK
SCHEMBL4025139 0.79 SRC (0.55) EGFRSRCKDRCSKTEK
SCHEMBL4027347 0.79 EGFR (0.52) EGFRSRCKDRCSKTEK
SCHEMBL4021449 0.78 SRC (0.54) EGFRSRCKDRCSKTEK
SCHEMBL4023711 0.78 KDR (0.53) EGFRSRCKDRCSKTEK
SCHEMBL6164850 0.77 SRC (0.50) EGFRSRCKDRCSKTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528925-B1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-04-22 EP claimed